Shusterman N[Author] - Search Results

Year	Number of Results
1978	2
1984	1
1985	2
1986	2
1987	4
1989	3
1991	1
1992	3
1993	1
1996	4
1998	2
1999	2
2000	3
2001	1
2002	1
2009	2
2013	1
2017	1
2018	1
2019	1
2024	0

1

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. Packer M, et al. Among authors: shusterman nh. N Engl J Med. 1996 May 23;334(21):1349-55. doi: 10.1056/NEJM199605233342101. N Engl J Med. 1996. PMID: 8614419 Free article. Clinical Trial.

2

Pharmacokinetics, Clinical Efficacy, Safety Profile, and Patient-Reported Outcomes in Patients Receiving Subcutaneous Testosterone Pellets 900 mg for Treatment of Symptoms Associated With Androgen Deficiency.

McMahon CG, Shusterman N, Cohen B. McMahon CG, et al. Among authors: shusterman n. J Sex Med. 2017 Jul;14(7):883-890. doi: 10.1016/j.jsxm.2017.04.734. J Sex Med. 2017. PMID: 28673432 Free article. Clinical Trial.

3

Risk-benefit assessment of angiotensin II receptor antagonists.

Shusterman N. Shusterman N. Expert Opin Drug Saf. 2002 Jul;1(2):137-52. doi: 10.1517/14740338.1.2.137. Expert Opin Drug Saf. 2002. PMID: 12904148 Review.

4

Reprocessing of hemodialyzers: a critical appraisal.

Shusterman NH, Feldman HI, Wasserstein A, Strom BL. Shusterman NH, et al. Am J Kidney Dis. 1989 Aug;14(2):81-91. doi: 10.1016/s0272-6386(89)80181-7. Am J Kidney Dis. 1989. PMID: 2667347 Free article. Review.

5

Safety and efficacy of eprosartan, a new angiotensin II receptor blocker.

Shusterman NH. Shusterman NH. Am Heart J. 1999 Sep;138(3 Pt 2):238-45. doi: 10.1016/s0002-8703(99)70316-9. Am Heart J. 1999. PMID: 10467219 Review.

6

Current topics in opioid therapy for pain management: addressing the problem of abuse.

Casty FE, Wieman MS, Shusterman N. Casty FE, et al. Among authors: shusterman n. Clin Drug Investig. 2013 Jul;33(7):459-68. doi: 10.1007/s40261-013-0087-8. Clin Drug Investig. 2013. PMID: 23740336 Review.

7

Erythrocyte sedimentation rate.

Shusterman N, Morrison G, Singer I, Kimmel P, Kiechle F. Shusterman N, et al. Am J Med. 1986 May;80(5):A66, A72. Am J Med. 1986. PMID: 3706360 No abstract available.

8

Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers.

Priestley T, Chappa AK, Mould DR, Upton RN, Shusterman N, Passik S, Tormo VJ, Camper S. Priestley T, et al. Among authors: shusterman n. Pain Med. 2018 Oct 1;19(10):1988-1996. doi: 10.1093/pm/pnx235. Pain Med. 2018. PMID: 29036723

9

Collagenase Clostridium Histolyticum for the Treatment of Edematous Fibrosclerotic Panniculopathy (Cellulite): A Randomized Trial.

Sadick NS, Goldman MP, Liu G, Shusterman NH, McLane MP, Hurley D, Young VL. Sadick NS, et al. Among authors: shusterman nh. Dermatol Surg. 2019 Aug;45(8):1047-1056. doi: 10.1097/DSS.0000000000001803. Dermatol Surg. 2019. PMID: 30829779 Free PMC article. Clinical Trial.

10

The erythrocyte sedimentation rate and chronic renal failure.

Shusterman N, Morrison G, Singer I, Kimmel P, Kiechle F. Shusterman N, et al. Ann Intern Med. 1986 Nov;105(5):801. doi: 10.7326/0003-4819-105-5-801_1. Ann Intern Med. 1986. PMID: 3767166 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year